Our News on Newswise

Newswise: jnccn1811_Cover.jpg

New Research in JNCCN Evaluates Cost-Effectiveness of Olaparib, a PARP Inhibitor, for Metastatic Pancreatic Cancer

New research in the November 2020 issue of JNCCN identifies metastatic pancreatic cancer patient subgroups with the highest relative cost-effectiveness from maintenance olaparib, a PARP inhibitor.
11-Nov-2020 4:00 PM EST Add to Favorites

Newswise: BG-Photo.jpg

NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development

The National Comprehensive Cancer Network® (NCCN®) today announced the addition of Beth Gaffney, MBA, as the new Vice President of U.S. and Global Business Development, overseeing licensing and other collaborations.
27-Oct-2020 8:35 AM EDT Add to Favorites

NCCN Oncology Research Program and Puma Biotechnology, Inc. Collaborate to Study Neratinib in Various Cancers

The NCCN Oncology Research Program (ORP) plans to evaluate neratinib, a type of tyrosine kinase inhibitor (TKI) that works as a dual inhibitor of the epidermal growth factor receptor 1 (EGFR) and human epidermal growth factor receptor 2 (HER2),...
15-Oct-2020 8:35 AM EDT Add to Favorites

Newswise: jnccnOctober-cover.jpg

JNCCN: New Research Finds Low Bone Health Testing Rates after Prostate Cancer Treatment

New research in the October 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the rate of bone mineral density (BMD) testing in people with prostate cancer undergoing androgen deprivation therapy (ADT) has improved in...
7-Oct-2020 8:35 AM EDT Add to Favorites

Newswise: Breast-Cancer-Translations.jpg

Expert Breast Cancer Treatment Recommendations Based on Latest Evidence Updating for Multiple Languages

Ongoing updates are underway for NCCN Guidelines for Breast Cancer in Chinese, English, French, Japanese, Korean, Spanish, Polish, and Portuguese, free online at NCCN.org/global. Follow #NCCNGlobal for more. The NCCN Foundation is hosting free...
5-Oct-2020 8:35 AM EDT Add to Favorites

Newswise: PEDHodgkin_Cover.png

New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma

The National Comprehensive Cancer Network announces publication of new NCCN Guidelines for Pediatric Hodgkin Lymphoma, one of the most curable forms of pediatric cancer. They synthesize the latest evidence and expert-consensus to make sure every...
23-Sep-2020 4:30 PM EDT Add to Favorites

Newswise: PediatricALLCover.jpg

New NCCN Resource for Understanding Childhood Leukemia

NCCN publishes a new patient and caregiver resource focused on a childhood cancer type. Free NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia (ALL) shares the latest expert advice for treating infants, children, and adolescents...
22-Sep-2020 11:05 AM EDT Add to Favorites

NCCN Policy Summit Explores How to Lower Costs for Cancer Care

NCCN Virtual Policy Summit features congressional staffers and representatives from CMS, COA, BIO, and others, discussing legislative and regulatory approaches for reducing health care costs.
9-Sep-2020 2:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Contacts

Rachel Darwin
Public Relations Manager

darwin@nccn.org

267-622-6624

Mary Ellen Martelli
Accounting Cordinator

martelli@nccn.org

267-622-6636

Erin Frantz

frantz@nccn.org

Jenn Tredwell

tredwell@nccn.org

Jessica Wilbur

wilbur@nccn.org

Twitter

close
0.35415